A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Active:	Yes
Cancer Type:	Esophogeal Cancer Stomach/ Gastric Cancer Unknown Primary	NCT ID:	NCT07221149
Trial Phases:	Phase II Phase III	Protocol IDs:	CA266-0004 (primary) NCI-2026-01091 2025-523263-37 U1111-1325-8116
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Bristol-Myers Squibb
NCI Full Details:	http://clinicaltrials.gov/show/NCT07221149

Summary

The purpose of this study is to evaluate the safety and efficacy of Pumitamig in
combination with chemotherapy versus Nivolumab in combination with chemotherapy in
participants with previously untreated advanced or metastatic gastric, gastroesophageal
junction, or esophageal adenocarcinoma

Treatment Sites in Georgia

Emory Johns Creek Hospital
6325 Hospital Parkway
Johns Creek, GA 30097
www.emoryjohnscreek.com

Emory University Hospital - Midtown
550 Peachtree Street NE
Atlanta, GA 30308
404-686-4411
www.emoryhealthcare.org

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.